Human leukocyte Antigen-DM polymorphisms in autoimmune diseases

Area of Science:

• Immunology
• Molecular Biology
• Autoimmunity

Background:

• Classical MHC class II (MHCII) molecules present peptides to CD4(+) T cells and are linked to autoimmune disorders.
• Human leucocyte antigen-DM (DM) is a non-classical MHCII molecule that edits peptides presented by classical MHCII proteins.
• DM's function is critical for pathogen response and self-tolerance, impacting T-cell development and peripheral surveillance.

Purpose of the Study:

• To review current knowledge on DM function in peptide editing.
• To discuss the potential role of DM activity in the development of autoimmune disorders.
• To highlight recent findings providing experimental evidence for differing DM catalytic efficiencies.

Main Methods:

• Review of biochemical and structural investigations of DM.
• Analysis of new animal models with impaired DM activity.
• Discussion of the implications of DM allotype-specific catalytic efficiencies.

Main Results:

• DM acts as a crucial peptide editor for classical MHCII molecules.
• DM activity influences both immune responses to pathogens and the maintenance of self-tolerance.
• Emerging evidence suggests variations in DM catalytic efficiency among different allotypes.

Conclusions:

• DM's role as a peptide editor is central to immune regulation.
• Altered DM function, particularly variations in catalytic efficiency, may represent a novel mechanism contributing to autoimmunity.
• Further research into DM allotypes is warranted to understand its full impact on health and disease.